ArticleLipids in health and disease2025
Comparison of the TyG index, TyG-traditional obesity indices, and TyG-novel obesity indices: does increased complexity help in predicting cardiometabolic multimorbidity?
Article in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Anthropometry-adjusted TyG indices predict diabetes, graft failure, and mortality in kidney transplant recipients.Journal of the Endocrine Society · 2026Article
- Association of 14 triglyceride-glucose (TyG)-related indices with new-onset cardiovascular disease in middle-aged and older adults: evidence from the CHARLS and ELSA aging cohorts.Cardiovascular diabetology · 2026Article
- Effects of adiposity, insulin resistance, and inflammation on cardiometabolic multimorbidity: insights from interaction analyses and metabolic phenotyping in the China health and retirement longitudinal study 2011-2018.Cardiovascular diabetology · 2026Article
- Unraveling 'F' factor: towards a genetic-clinical framework for the musculoskeletal-heart crosstalk in metabolic aging.Cardiovascular diabetology · 2026Article
- Article
- Predictive value of cholesterol, high-density lipoprotein, and glucose index-obesity-derived index for stroke: a cohort study.Lipids in health and disease · 2026Article
- Association of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose and its modified indices with cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a longitudinal analysis based on CHARLS.Cardiovascular diabetology · 2026Article
- Associations of nine insulin resistance-related indices with the incidence and progression of cardiovascular-liver-metabolic multimorbidity: a large prospective cohort study.Cardiovascular diabetology · 2026Article
- Association of cumulative exposure and change patterns of triglyceride-glucose index combined with novel obesity indices with glycemic transitions in prediabetes: evidence from the China Health and Retirement Longitudinal Study (CHARLS).Cardiovascular diabetology · 2026Article
- Associations of eight insulin resistance-related indices and genetic risk with incident cardiometabolic multimorbidity among participants with hypertension: a large prospective cohort study.Cardiovascular diabetology · 2026Observational
- Association of the triglyceride glucose-Chinese visceral adiposity index with incident cardiometabolic multimorbidity in middle-aged and older adults: a nationwide prospective cohort study.Cardiovascular diabetology · 2026Article
- From traditional to novel: a national cohort study on the predictive value of C-reactive protein-triglyceride-glucose-obesity composite parameters for cardiovascular disease.Therapeutic advances in endocrinology and metabolism · 2026Article
- TyG-WHtR predicts incident type 2 diabetes mellitus in NAFLD: a 12-year prospective cohort study.Frontiers in endocrinology · 2026Article
- The Triglyceride-Glucose-Chinese Visceral Adiposity Index (TyG-CVAI) outperforms other insulin resistance indices in its association with cardiovascular-kidney-metabolic syndrome severity in type 2 diabetes: a comparative study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe triglyceride-glucose (TyG) index is an important determinant influencing the incidence of cardiometabolic multimorbidity (CMM). However, it remains unclear whether combining the TyG index with novel obesity indices (CVAI/BRI/ABSI/WWI) can improve the risk stratification of CMM. This study aimed to systematically compare the incremental risk assessment and predictive value of the TyG index, TyG-traditional obesity indices (TyG-WC/TyG-WHtR/TyG-BMI), and TyG-novel obesity indices (TyG-CVAI/TyG-BRI/TyG-ABSI/TyG-WWI) for CMM.
methodsTrajectory changes and cumulative exposure of TyG-related parameters were quantified using repeated measurements from the CHARLS cohort (n = 3,885). The study endpoint CMM was defined as a comorbid condition encompassing two or more cardiometabolic diseases, namely diabetes, stroke and heart diseases. A multi-model analytical strategy was employed to evaluate the associations between TyG-related parameters and CMM, as well as the contribution of their components. The net reclassification index and integrated discrimination improvement were employed to evaluate the improvement in predictive performance of these indices.
resultsOver a median follow-up period of 8 years, we identified a linear positive association between TyG-related parameters and CMM, with the cumulative effects of glucose and obesity emerging as the key drivers. Compared with the baseline TyG index, the incremental risk assessment value for CMM improved by 10%-17% (baseline) and 12%-20% (cumulative exposure) for TyG-traditional obesity indices, while the improvement for TyG-novel obesity indices ranged from - 1% to 16% and 5%-19%, respectively. In summary, all TyG-traditional obesity indices demonstrated strong associations with CMM, whereas among the TyG-novel obesity indices, only TyG-CVAI showed a similarly strong association. Furthermore, all TyG-related parameters showed significantly increased hazard ratios in their highest-exposure or poor-control status versus the reference (lowest exposure or good control): TyG-index (1.69/2.05), TyG-WC (2.24/2.28), TyG-WHtR (1.92/2.05), TyG-BMI (1.85/2.27), TyG-CVAI (1.89/2.07), TyG-BRI (1.94/2.08), TyG-ABSI (1.70/1.85), and TyG-WWI (1.97/1.95). Predictive analyses showed that, except for TyG index, TyG-ABSI and TyG-WWI, all other TyG-related parameters provided a certain degree of net improvement compared with the baseline risk model.
conclusionAll eight TyG-related parameters can predict the incidence of CMM. Given their relative simplicity, the TyG-traditional obesity indices demonstrate superior incremental risk assessment and predictive value for CMM compared to the TyG-novel obesity indices and the TyG index, positioning them as promising and more practical tools for clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.